MedTrace Logo

Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain

NCT02794922 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-05-04

No results posted yet for this study

Summary

The purpose of this study is to determine effectiveness of vitamin B in reducing temporomandibular joint disorder (TMD) pain. Patients will be randomised to receive the study drug or placebo. The study drug we are using is a combination of vitamin B1(thiamine mononitrate)-242.5mg; vitamin B6(pyridoxineHCl)-250mg, and vitamin B12(cyanocobalamin)-1mg. We will assess patient's pain level, range of jaw movement and record any side effects from using this medication.

Conditions

  • Temporomandibular Joint Disorder

Interventions

DRUG

Neurovit Forte

DRUG

Corn Starch

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Winnie Wing Shan Choi, BDS, MDS · Faculty of Dentistry, The University of Hong Kong

  • Jothi R Rajaran, DDS · Faculty of Dentistry, The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-06-30
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794922 on ClinicalTrials.gov